Skip to main content
OpenTrials
Recruiting

NCT Number: NCT07052344

Gut-Brain Neural Coupling in Spinal Cord Injury

The purpose of this research is to determine the effects of food on brain and stomach activity in persons with and without spinal cord injury (SCI).

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–70 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

, SCI and Controls

  • Adults, 18 to 70 years of age.
  • Sex, male or female.
  • Weight-stable (±3 kg) for the preceding 3 months (self-report).
  • Physically inactive adults not meeting weekly activity guidelines (<150 min/week) for the preceding 3 months (self-report).
  • Fluent in written and spoken English.

Exclusion criteria

, SCI and Controls

  • Do not meet the inclusion criteria.
  • Current/regular smoker (defined by Center for Disease Control (CDC)/ National Institute of Health (NIH) as an adult who has smoked 100 cigarettes in his or her lifetime and who currently smokes either every day or every other day) (self-report).
  • Currently dieting and/or trying to gain or lose weight.
  • Vagus or recurrent laryngeal nerve injury (self-report).
  • Uncontrolled thyroid disease, such that they are not on thyroid medication (e.g., levothyroxine) to treat the condition (self-report)
  • Diabetes (type 1 or type 2) and/or currently taking anti-diabetic or glucagon-like peptide-1 (GLP-1)/dual agonist medications (self-report).
  • Gastrointestinal disease (self-report), such as inflammatory bowel disease (e.g. Crohn's disease, ulcerative colitis), celiac disease, irritable bowel syndrome, gastroesophageal reflux disease, peptic ulcer disease, chronic pancreatitis, liver cirrhosis, and any condition requiring gastrointestinal surgery (e.g., bowel resection, colostomy, or ileostomy).
  • Swallowing disorder (self-report).
  • History of bariatric surgery
  • Food allergies/dislikes or dietary restrictions (i.e. vegan) (self-report).
  • Allergy to adhesives (self-report)
  • Open abdominal wounds or abdominal skin not intact.
  • Current use of probiotics/prebiotics (self-report).
  • Current use of medications that can impact appetite, body weight, and/or bowel function, such as prokinetic, antiemetic, narcotic analgesics, anticholinergic, anti-inflammatory, antipsychotic, or anti-obesity agents (self-report).
  • Pregnant (determined by urine pregnancy test) or breastfeeding women.
  • Non-adults (infants, children, teenagers).
  • Adults unable to consent
  • Prisoner.

SCI-specific Eligibility Criteria

Inclusion criteria

, SCI Only

  • At least 12 months post-SCI, denoting chronic injury
  • Complete American Spinal Injury Association (ASIA) Impairment Scale (AIS A) or motor-incomplete (AIS B) tetraplegia (SCI at or above C8 lesion)
  • Able to self-feed (self-report)
  • On a bowel care program every day or every other day (self-report).

Exclusion criteria

, SCI Only

  • Under 12 months post-SCI.
  • Motor-incomplete (AIS C, D) paraplegia (SCI below C8 lesion), including thoracic, lumbar, and sacral injuries.
  • Ventilator-dependence (self-report).

Treatment and study plan

Preload condition

Other

Participants will consume a fixed compulsory preload meal of Campbell's Tomato soup (~300 grams) 30 minutes after the baseline assessments. Fifteen minutes after consuming the preload meal, participants will receive the ad libitum test meal, consisting of a pre-weighed serving of Stouffer's Macaroni and Cheese (~700 g).The pre-load condition will be completed at only one of two visits. Participation will be up to 2 weeks with the visits separated by up to 2 weeks. Duration for the pre-load condition visit will be up to 6 hours

Ad-libitum control condition

Other

Participants will only consume the ad libitum test meal, which consists of a pre-weighted serving of Stouffer's Macaroni and Cheese (~700 g). The ad-libitum meal will be consumed at both visits. Participation will be up to 2 weeks with the visits separated by up to 2 weeks. The ad-libitum control condition visit will take up to 2 hours.

Primary outcomes

  1. Phase amplitude coupling (PAC) strength

    Time frame: up to 2 weeks

    Gut-brain connectivity will be assessed using phase-amplitude coupling (PAC) to examine the interaction between gastric electrical oscillations and cortical rhythms. PAC will be calculated from electrophysiological raw data to produce one unitless value ranging from -1 to 1, for each subject. The higher the value, the greater the gut-brain connectivity/PAC strength.

Study contacts

Contact information is provided by the study sponsor or research team.

Gary J Farkas, PhD

CONTACT

[email protected]

305-243-4518

Guillermo Mederos

CONTACT

[email protected]

305-243-4518

Sponsors and collaborators

Lead sponsor

University of Miami

Other

Registry information

Important dates

Study start
2025
Primary completion
2026
Study completion
2026
First posted
Jul 4, 2025
Registry last updated
Jul 17, 2026

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.